aTyr Pharma Inc (NASDAQ:LIFE)

Delayed Data
As of Jan 24
 +0.06 / +1.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 19.50, with a high estimate of 22.00 and a low estimate of 11.00. The median estimate represents a +222.58% increase from the last price of 6.05.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 32.54%
Growthannually -1.32%


Growthquarterly --
Growthannually -79.37%
Key to the earnings and sales forecast charts.